229 related articles for article (PubMed ID: 35072575)
1. Current options and investigational drugs for the treatment of eosinophilic esophagitis.
Tamarit-Sebastian S; Ferrer-Soler FM; Lucendo AJ
Expert Opin Investig Drugs; 2022 Feb; 31(2):193-210. PubMed ID: 35072575
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
Lucendo AJ
Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634
[No Abstract] [Full Text] [Related]
3. Drug treatment strategies for eosinophilic esophagitis in adults.
Lucendo AJ
Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for eosinophilic esophagitis.
Meek PD; Hemstreet B
Pharmacotherapy; 2023 Apr; 43(4):338-348. PubMed ID: 36840634
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for eosinophilic esophagitis.
Pesek RD; Gupta SK
Expert Opin Emerg Drugs; 2018 Jun; 23(2):173-183. PubMed ID: 29848130
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.
Feo-Ortega S; Lucendo AJ
Therap Adv Gastroenterol; 2022; 15():17562848211068665. PubMed ID: 35069803
[TBL] [Abstract][Full Text] [Related]
7. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis.
Syverson EP; Hait E
Gastroenterol Hepatol (N Y); 2022 Apr; 18(4):207-212. PubMed ID: 35505944
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.
Schoepfer AM; Straumann A; Safroneeva E
Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):77-88. PubMed ID: 29129301
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options and long-term outcomes in patients with eosinophilic esophagitis.
Lucendo AJ; Molina-Infante J
Expert Rev Clin Immunol; 2022 Aug; 18(8):859-872. PubMed ID: 35770955
[TBL] [Abstract][Full Text] [Related]
10. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
11. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches.
Chen JW
Nutr Clin Pract; 2020 Oct; 35(5):835-847. PubMed ID: 32822071
[TBL] [Abstract][Full Text] [Related]
12. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
13. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
Ridolo E; Barone A; Ottoni M; Peveri S; Montagni M; Nicoletta F
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338983
[TBL] [Abstract][Full Text] [Related]
14. Advances in clinical management of eosinophilic esophagitis.
Dellon ES; Liacouras CA
Gastroenterology; 2014 Dec; 147(6):1238-54. PubMed ID: 25109885
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic esophagitis: short and long-term considerations.
Goyal A
Curr Opin Pediatr; 2018 Oct; 30(5):646-652. PubMed ID: 30015687
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
[TBL] [Abstract][Full Text] [Related]
18. Medical and dietary management of eosinophilic esophagitis.
Nhu QM; Aceves SS
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):156-161. PubMed ID: 29753831
[TBL] [Abstract][Full Text] [Related]
19. The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
Molina-Infante J; Prados-Manzano R; Gonzalez-Cordero PL
Expert Rev Clin Immunol; 2016 Sep; 12(9):945-52. PubMed ID: 27097787
[TBL] [Abstract][Full Text] [Related]
20. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
